Boehringer Ingelheim Senior Associate Director, Competitive Intelligence in RIDGEFIELD, Connecticut
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities.
The CI Expert will be responsible for actively driving and implementing the CI strategy in support of a diverse preclinical and clinical pipeline of assets for Cardiometabolic Diseases Research (CMDR) and Research Beyond Borders (RBB), both located within the BI Innovation Unit. Current R&D efforts within these functions are focused on Diabetic Nephropathy, Non Alcoholic Steatohepatitis (NASH) and related indications on the Cardiometabolic Diseases Research side, as well as a variety of indications (e.g. Wound healing) scientific fields (e.g. microbiome-related research), Pathways, gene families or protein families (e.g. Epigenetics target class)are of interest to the RBB group.
In this role, the CI Expert will leverage a variety of data and his / her network in the cardiometabolic / cardio renal academic and drug discovery space as well as his/her capacity to learn new diseases/areas, to deliver continuous, comprehensive and relevant CI information to the TA and RBB, and summarize strategic implications for review by local and global BI Executives.
The CI Expert will further build and leverage a network of key internal stakeholders across functions to complement external CI and determine strategic fit for advanced and early pipeline assets in DN. Further, the Expert will support Early Portfolio entry decisions and will leverage information from existing academic and business collaborations for contributing to a full assessment of unmet needs and market opportunities in the cardio renal and the wider drug discovery space of interest to RBB.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees
Duties & Responsibilities:
Monitor, search, analyze and present Competitive Intelligence landscape information to the CMDR TA leadership team (CLT) and to RBB Core Team in support of strategic portfolio and partnering decisions. Develop and maintain a comprehensive and accessible overview of the competitive landscape in the cardiometabolic/RBB relevant space, including but not limited to data on, and interpretations of, news regarding milestones or terminations of preclinical and clinical development programs in the DN / NASH, cardiometabolic space and a variety of indications relevant to RBB.
Contribute expert CI assessments to local and global strategic update presentations throughout the year. Coordinate these assessments with global CI partners supporting CMDR and RBB at other research sites, and tailor them to the needs of key stakeholders to effectively and proactively support program positioning and differentiation.
Work closely with business partners in Medical, Marketing and Business Development & Licensing (BD&L) to develop timely and comprehensive value propositions for internal and external investments in areas of strategic interest in support of CMDR and RBB. Participate in analysis of due diligence evaluations for external partnering opportunities as needed.
Map out and maintain a relevant list of domestic and international key conferences and meetings in the cardiometabolic/ RBB relevant disease space and help coordinate CI collection at these meetings with local and global CMDR / RBB scientists. Leverage internal and external database and CI resources including BI Libraries for maintaining the highest level of information sourcing at all times. Ensure access to up-to-date commercial reports on developments in the cardiometabolic / RBB relevant disease space for key stakeholders
Master's degree from an accredited institution required
Doctoral degree, from an accredited institution, with a focus in Life Science or relevant field is preferred
At least ten (10) years’ experience in drug R&D, translational research or licensing in the global biopharmaceutical industry with a focus on cardiometabolic / metabolic / cardiorenal / cardiovascular research and drug discovery and development.
Understanding of the competitive landscape, challenges and opportunities in the DN / NASH drug development and commercialization space.
Competitive Intelligence (CI) expertise with the curiosity and capacity to learn new diseases/areas.
Strong people / relation-building skills and excellent verbal and written communication and presentation skills.
Ability to work productively in a fast-paced, global and culturally diverse environment and ability to adapt working style to evolving strategic priorities as necessary.
Ability to travel both domestically and internationally.
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighborhoods where we live and work. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.
Organization: US-BI Pharma/BI USA
Title: Senior Associate Director, Competitive Intelligence
Location: Americas-United States-CT-Ridgefield
Requisition ID: 176603